Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

The U.S. District Judge Jed Rakoff has revoked his earlier order to dismiss a major portion of the lawsuit filed by Brussels based Dexia N.V./S.A against JPMorgan Chase & Co. (JPM - Analyst Report). The lawsuit accused JPMorgan of deliberately selling risky mortgage-backed securities (MBS) worth $1.6 billion to Dexia during the housing boom prior to the 2008 financial meltdown.

In justifying the revival of the lawsuit, Rakoff stated that he lacked any jurisdiction under the Edge Act to dismiss the case. Further, citing the ruling of 2nd U.S. Circuit Court of Appeals in New York for American International Group, Inc.’s (AIG - Analyst Report) lawsuit against Bank of America Corporation (BAC - Analyst Report), Rakoff decided to reverse his decision for the above-mentioned lawsuit.

Now, the trial will resurface in the New York state court, where it began in Jan 2012, when Dexia sued JPMorgan along with its affiliates – The Bear Stearns Companies, Inc and Washington Mutual, Inc. According to the subsidiary of Dexia – FSA Asset Management LLC – the accused clearly knew of the risks associated with the mortgage securities. However, JPMorgan allegedly sold massive quantities of these securities to Dexia to reduce its own exposure.

The Dexia lawsuit attracted media attention after a series of emails were discovered suggesting JPMorgan’s sale of massive quantities of these securities, while being aware of the associated risks.

In Apr 2013, Rakoff had allowed Dexia to proceed with only 5 claims, while dismissing nearly 60 claims. This significantly slashed the potential legal settlement to $5.7 million from $774 million.

Apart from JPMorgan, other banks including BofA and Morgan Stanley (MS - Analyst Report) continue to face lawsuits concerning the sale of MBS prior to the economic crisis. In addition, JPMorgan faces a number of other lawsuits alleging legal malfeasance.

Over the last couple of years, JPMorgan has been doling out millions to settle litigations. However, the company’s strong fundamentals continue to act as a catalyst.

JPMorgan currently carries a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
GENERAL FINA GFN 8.20 +5.67%
QIHOO 360 TE QIHU 91.57 +4.38%
VIPSHOP HOLD VIPS 140.01 +3.49%
INVESTMENT T ITG 19.16 +3.34%
VERTEX ENERG VTNR 7.38 +3.07%